Docking and scoring: applications to drug discovery in the interactomics era

被引:12
|
作者
Grosdidier, Solene [1 ]
Fernandez-Recio, Juan [1 ]
机构
[1] Barcelona Supercomp Ctr, Dept Life Sci, Barcelona 08034, Spain
关键词
hot-spots; protein-protein docking; protein-protein interactions; virtual ligand screening; PROTEIN-PROTEIN DOCKING; LIGAND BINDING-SITES; HOT-SPOTS; SMALL-MOLECULE; SHAPE COMPLEMENTARITY; ENCOUNTER COMPLEX; ALLOSTERIC MODULATORS; BIOLOGICAL FUNCTION; PEPTIDE INHIBITOR; CYTOKINE-RECEPTOR;
D O I
10.1517/17460440903002067
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available data on the use of these computational techniques to target protein-protein interactions. Objective: To establish a strategy for the use of current computational tools in drug discovery targeting protein-protein interactions. Method: Individual techniques applied to specific cases could be studied to derive a general strategy for targeting protein-protein interactions. Conclusion: Protein docking, interface prediction and hot-spot identification can contribute to the discovery of small molecule inhibitors targeting protein interactions of therapeutic interest, especially when little structural information is available.
引用
收藏
页码:673 / 686
页数:14
相关论文
共 50 条
  • [1] Docking and scoring in virtual screening for drug discovery: methods and applications
    Douglas B. Kitchen
    Hélène Decornez
    John R. Furr
    Jürgen Bajorath
    [J]. Nature Reviews Drug Discovery, 2004, 3 : 935 - 949
  • [2] Docking and scoring in virtual screening for drug discovery: Methods and applications
    Kitchen, DB
    Decornez, H
    Furr, JR
    Bajorath, J
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) : 935 - 949
  • [3] Ligand docking and scoring: New techniques and applications in drug discovery
    Kellogg, GE
    [J]. MEDICINAL CHEMISTRY RESEARCH, 1999, 9 (7-8) : 439 - 442
  • [4] Quantum-Mechanics Methodologies in Drug Discovery: Applications of Docking and Scoring in Lead Optimization
    Crespo, Alejandro
    Rodriguez-Granillo, Agustina
    Lim, Victoria T.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (23) : 2663 - 2680
  • [5] The use of scoring functions in drug discovery applications
    Böhm, HJ
    Stahl, M
    [J]. REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 18, 2002, 18 : 41 - 87
  • [6] Docking and scoring in Discovery Studio
    Maynard, Allister J.
    Ehlers, Tedman
    Koska, Juergen
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [7] CREDO: a structural interactomics database for drug discovery
    Schreyer, Adrian M.
    Blundell, Tom L.
    [J]. DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2013,
  • [8] Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
    Kumalo, Hezekiel Mathambo
    Bhakat, Soumendranath
    Soliman, Mahmoud E. S.
    [J]. MOLECULES, 2015, 20 (02): : 1984 - 2000
  • [9] Molecular Docking: Principles, Advances, and its Applications in Drug Discovery
    Muhammed, Muhammed Tilahun
    Aki-Yalcin, Esin
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (03) : 480 - 495
  • [10] Signposts of docking and scoring in drug design
    Gani, Osman A. B. S. M.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2007, 70 (04) : 360 - 365